Potential mechanisms underlying the role of chronic inflammation in age-related muscle wasting

Aging Clinical and Experimental Research

Volumn 24, Issue 5, 2012, Pages 412-422

  Jo, Edward ^a   Lee, Sang Rok ^a   Park, Bong Sup ^a   Kim, Jeong Su ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Aging; Inflammation; Obesity; Sarcopenia

Indexed keywords

ATROGIN 1; CASPASE; CYTOCHROME C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MYOD PROTEIN; MYOGENIN; PROTEASOME; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; AGING; APOPTOSIS; BODY COMPOSITION; CELL LINEAGE; CELL PROLIFERATION; CHRONIC INFLAMMATION; COMORBIDITY; DISEASE EXACERBATION; DISEASE SEVERITY; GENE EXPRESSION; HUMAN; INSULIN RESISTANCE; MORBIDITY; MUSCLE ATROPHY; MUSCLE INJURY; MUSCLE MASS; MUSCLE REGENERATION; MUSCLE STRENGTH; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SATELLITE CELL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSCRIPTION REGULATION; UPREGULATION;

AGED; AGING; ANIMALS; FEMALE; HUMANS; INFLAMMATION; LIFE STYLE; LIPIDS; MALE; MUSCLE, SKELETAL; OXIDATIVE STRESS; SARCOPENIA; SEX FACTORS; TIME FACTORS;

EID: 84866993612     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.3275/8464     Document Type: Review

References (124)

1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr 1997; 127 (Suppl 5): 990S-1S.
2. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002; 50: 889-96.
3. Janssen I, Heymsfield SB, Wang ZM, Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol 2000; 89: 81-8.
4. Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci 2002; 57: M772-7.
5. Murray MP, Duthie EH Jr, Gambert SR, Sepic SB, Mollinger LA. Age-related differences in knee muscle strength in normal women. J Gerontol 1985; 40: 275-80.
6. Murray MP, Gardner GM, Mollinger LA, Sepic SB. Strength of isometric and isokinetic contractions: knee muscles of men aged 20 to 86. Phys Ther 1980; 60: 412-9.
7. Baumgartner RN, Koehler KM, Gallagher D et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147: 755-63.
8. Aniansson A, Sperling L, Rundgren A, Lehnberg E. Muscle function in 75-year-old men and women. A longitudinal study. Scand J Rehabil Med Suppl 1983; 9: 92-102.
9. Tinetti ME, Williams CS. Falls, injuries due to falls, and the risk of admission to a nursing home. N Engl J Med 1997; 337: 1279-84.
10. Wolfson L, Judge J, Whipple R, King M. Strength is a major factor in balance, gait, and the occurrence of falls. J Gerontol A Biol Sci Med Sci 1995; 50 (Spec No): 64-7.
11. Dorsey KB, Thornton JC, Heymsfield SB, Gallagher D. Greater lean tissue and skeletal muscle mass are associated with higher bone mineral content in children. Nutr Metab (Lond) 2010; 7: 41. PMCID: 2886077.
12. Clark BC, Manini TM. Functional consequences of sarcopenia and dynapenia in the elderly. Curr Opin Clin Nutr Metab Care 2010; 13: 271-6. PMCID: 2895460.
13. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 2004; 52: 80-5.
14. Buford TW, Anton SD, Judge AR et al. Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy. Ageing Res Rev 2010; 9: 369-83.
15. Greenlund LJ, Nair KS. Sarcopenia - consequences, mechanisms, and potential therapies. Mech Ageing Dev 2003; 124: 287-99.
16. Roubenoff R. The pathophysiology of wasting in the elderly. J Nutr 1999; 129 (1S Suppl): 256S-9S.
17. Glass D, Roubenoff R. Recent advances in the biology and therapy of muscle wasting. Ann NY Acad Sci 2010; 1211: 25-36.
18. Siu PM, Pistilli EE, Alway SE. Age-dependent increase in oxidative stress in gastrocnemius muscle with unloading. J Appl Physiol 2008; 105: 1695-705. PMCID: 2612472.
19. Moylan JS, Reid MB. Oxidative stress, chronic disease, and muscle wasting. Muscle Nerve 2007; 35: 411-29.
20. Chung HY, Cesari M, Anton S et al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev 2009; 8: 18-30.
21. Buford TW, Cooke MB, Willoughby DS. Resistance exercise-induced changes of inflammatory gene expression within human skeletal muscle. Eur J Appl Physiol 2009; 107: 463-71.
22. Haddad F, Zaldivar F, Cooper DM, Adams GR. IL-6-induced skeletal muscle atrophy. J Appl Physiol 2005; 98: 911-7.
23. Schrager MA, Metter EJ, Simonsick E et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol 2007; 102: 919-25. PMCID: 2645665.
24. Roubenoff R. Physical activity, inflammation, and muscle loss. Nutr Rev 2007; 65: S208-12.
25. Handel ML, McMorrow LB, Gravallese EM. Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65. Arthritis Rheum 1995; 38: 1762-70.
26. Meng SJ, Yu LJ. Oxidative stress, molecular inflammation and sarcopenia. Int J Mol Sci 2010; 11: 1509-26. PMCID: 2871128.
27. Chung HY, Lee EK, Choi YJ et al. Molecular Inflammation as an underlying mechanism of the aging process and age-related diseases. J Dent Res 2011; 90: 830-40. doi: 10.1177/0022034510387794. Epub 2011 Mar 29.
28. Mourkioti F, Rosenthal N. IGF-1, inflammation and stem cells: interactions during muscle regeneration. Trends Immunol 2005; 26: 535-42.
29. Toth MJ, Matthews DE, Tracy RP, Previs MJ. Age-related differences in skeletal muscle protein synthesis: relation to markers of immune activation. Am J Physiol Endocrinol Metab 2005; 288: E883-91.
30. Dirks AJ, Leeuwenburgh C. Tumor necrosis factor alpha signaling in skeletal muscle: effects of age and caloric restriction. J Nutr Biochem 2006; 17: 501-8.
31. Cesari M, Kritchevsky SB, Baumgartner RN et al. Sarcopenia, obesity, and inflammation - results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am J Clin Nutr 2005; 82: 428-34.
32. Ferrante AW Jr. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J Intern Med 2007; 262: 408-14.
33. Thornell LE. Sarcopenic obesity: satellite cells in the aging muscle. Curr Opin Clin Nutr Metab Care 2011; 14: 22-7.
34. Carmeli E, Coleman R, Reznick AZ. The biochemistry of aging muscle. Exp Gerontol 2002; 37: 477-89.
35. Yu BP. Aging and oxidative stress: modulation by dietary restriction. Free Radic Biol Med 1996; 21: 651-68.
36. Kim DH, Kim CH, Kim MS et al. Suppression of age-related inflammatory NF-kappaB activation by cinnamaldehyde. Biogerontology 2007; 8: 545-54.
37. Kim HJ, Kim KW, Yu BP, Chung HY. The effect of age on cyclooxygenase- 2 gene expression: NF-kappaB activation and IkappaBalpha degradation. Free Radic Biol Med 2000; 28: 683-92.
38. Kim HK, Park HR, Lee JS, Chung TS, Chung HY, Chung J. Down-regulation of iNOS and TNF-alpha expression by kaempferol via NF-kappaB inactivation in aged rat gingival tissues. Biogerontology 2007; 8: 399-408.
39. Chung HY, Sung B, Jung KJ, Zou Y, Yu BP. The molecular inflammatory process in aging. Antioxid Redox Signal 2006; 8: 572-81.
40. Franceschi C, Bonafe M, Valensin S et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann NY Acad Sci 2000; 908: 244-54.
41. Karin M. Role for IKK2 in muscle: waste not, want not. J Clin Invest 2006; 116: 2866-8. PMCID: 1626137.
42. Zandi E, Chen Y, Karin M. Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NFkappaB- bound substrate. Science 1998; 281: 1360-3.
43. Li YP, Chen Y, John J et al. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. Faseb J 2005; 19: 362-70. PMCID: 3099533.
44. Li YP, Reid MB. NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes. Am J Physiol Regul Integr Comp Physiol 2000; 279: R1165-70.
45. Lee HC, Wei YH. Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int J Biochem Cell Biol 2005; 37: 822-34.
46. Fisher GJ, Datta SC, Talwar HS et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 1996; 379: 335-9.
47. Messina S, Vita GL, Aguennouz M et al. Activation of NFkappaB pathway in Duchenne muscular dystrophy: relation to age. Acta Myol 2011; 30: 16-23.
48. Reid MB, Li YP. Tumor necrosis factor-alpha and muscle wasting: a cellular perspective. Respir Res 2001; 2: 269-72. PMCID: 59514.
49. Glass DJ. Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol 2005; 37: 1974-84.
50. Jagoe RT, Lecker SH, Gomes M, Goldberg AL. Patterns of gene expression in atrophying skeletal muscles: response to food deprivation. Faseb J 2002; 16: 1697-712.
51. Hershko A. The ubiquitin system for protein degradation and some of its roles in the control of the cell-division cycle (Nobel lecture). Angew Chem Int Ed Engl 2005; 44: 5932-43.
52. Bodine SC, Latres E, Baumhueter S et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001; 294: 1704-8.
53. Glass DJ. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol 2003; 5: 87-90.
54. Li YP, Chen Y, Li AS, Reid MB. Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. Am J Physiol Cell Physiol 2003; 285: C806-12.
55. Lecker SH. Ubiquitin-protein ligases in muscle wasting: multiple parallel pathways? Curr Opin Clin Nutr Metab Care 2003; 6: 271-5.
56. Lecker SH, Solomon V, Mitch WE, Goldberg AL. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J Nutr 1999; 129 (1S Suppl): 227S-37S.
57. Clavel S, Coldefy AS, Kurkdjian E, Salles J, Margaritis I, Derijard B. Atrophy-related ubiquitin ligases, atrogin-1 and MuRF1 are upregulated in aged rat Tibialis Anterior muscle. Mech Ageing Dev 2006; 127: 794-801.
58. Sishi B, Loos B, Ellis B, Smith W, du Toit EF, Engelbrecht AM. Diet-induced obesity alters signalling pathways and induces atrophy and apoptosis in skeletal muscle in a prediabetic rat model. Exp Physiol 2011; 96: 179-93.
59. Cai D, Frantz JD, Tawa NE Jr et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 2004; 119: 285-98.
60. Wyke SM, Tisdale MJ. NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitinproteasome system in skeletal muscle. Br J Cancer 2005; 92: 711-21. PMCID: 2361865.
61. Reed SA, Senf SM, Cornwell EW, Kandarian SC, Judge AR. Inhibition of IkappaB kinase alpha (IKKalpha) or IKKbeta (IKKbeta) plus forkhead box O (Foxo) abolishes skeletal muscle atrophy. Biochem Biophys Res Commun 2011; 405: 491-6. PMCID: 3056397.
62. Li YP, Schwartz RJ, Waddell ID, Holloway BR, Reid MB. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. Faseb J 1998; 12: 871-80.
63. Raingeaud J, Gupta S, Rogers JS et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995; 270: 7420-6.
64. Murton AJ, Constantin D, Greenhaff PL. The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. Biochim Biophys Acta 2008; 1782: 730-43.
65. Edstrom E, Altun M, Hagglund M, Ulfhake B. Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle. J Gerontol A Biol Sci Med Sci 2006; 61: 663-74.
66. Whitman SA, Wacker MJ, Richmond SR, Godard MP. Contributions of the ubiquitin-proteasome pathway and apoptosis to human skeletal muscle wasting with age. Pflugers Arch 2005; 450: 437-46.
67. Hawke TJ, Garry DJ. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 2001; 91: 534-51.
68. Snijders T, Verdijk LB, van Loon LJ. The impact of sarcopenia and exercise training on skeletal muscle satellite cells. Ageing Res Rev 2009; 8: 328-38.
69. Hawke TJ. Muscle stem cells and exercise training. Exerc Sport Sci Rev 2005; 33: 63-8.
70. Petrella JK, Kim JS, Cross JM, Kosek DJ, Bamman MM. Efficacy of myonuclear addition may explain differential myofiber growth among resistance-trained young and older men and women. Am J Physiol Endocrinol Metab 2006; 291: E937-46.
71. Kadi F, Charifi N, Denis C, Lexell J. Satellite cells and myonuclei in young and elderly women and men. Muscle Nerve 2004; 29: 120-7.
72. Verdijk LB, Koopman R, Schaart G, Meijer K, Savelberg HH, van Loon LJ. Satellite cell content is specifically reduced in type II skeletal muscle fibers in the elderly. Am J Physiol Endocrinol Metab 2007; 292: E151-7.
73. Morse CI, Thom JM, Reeves ND, Birch KM, Narici MV. In vivo physiological cross-sectional area and specific force are reduced in the gastrocnemius of elderly men. J Appl Physiol 2005; 99: 1050-5.
74. Morse CI, Thom JM, Mian OS, Birch KM, Narici MV. Gastrocnemius specific force is increased in elderly males following a 12-month physical training programme. Eur J Appl Physiol 2007; 100: 563-70.
75. Verdijk LB, Gleeson BG, Jonkers RA et al. Skeletal muscle hypertrophy following resistance training is accompanied by a fiber type-specific increase in satellite cell content in elderly men. J Gerontol A Biol Sci Med Sci 2009; 64: 332-9. PMCID: 2655000.
76. Kim JS, Kosek DJ, Petrella JK, Cross JM, Bamman MM. Resting and load-induced levels of myogenic gene transcripts differ between older adults with demonstrable sarcopenia and young men and women. J Appl Physiol 2005; 99: 2149-58.
77. Degens H. Age-related skeletal muscle dysfunction: causes and mechanisms. J Musculoskelet Neuronal Interact 2007; 7: 246-52.
78. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005; 433: 760-4.
79. Rader EP, Faulkner JA. Recovery from contraction-induced injury is impaired in weight-bearing muscles of old male mice. J Appl Physiol 2006; 100: 656-61.
80. Rader EP, Faulkner JA. Effect of aging on the recovery following contraction-induced injury in muscles of female mice. J Appl Physiol 2006; 101: 887-92.
81. Carlson BM, Faulkner JA. Muscle transplantation between young and old rats: age of host determines recovery. Am J Physiol 1989; 256: C1262-6.
82. Degens H. The role of systemic inflammation in age-related muscle weakness and wasting. Scand J Med Sci Sports 2010; 20: 28-38.
83. Langen RC, Schols AM, Kelders MC, van der Velden JL, Wouters EF, Janssen-Heininger YM. Muscle wasting and impaired muscle regeneration in a murine model of chronic pulmonary inflammation. Am J Respir Cell Mol Biol 2006; 35: 689-96.
84. Langen RC, Van Der Velden JL, Schols AM, Kelders MC, Wouters EF, Janssen-Heininger YM. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. Faseb J 2004; 18: 227-37.
85. Chen SE, Jin B, Li YP. TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK. Am J Physiol Cell Physiol 2007; 292: C1660-71. PMCID: 3099536.
86. Langen RC, Schols AM, Kelders MC, Van Der Velden JL, Wouters EF, Janssen-Heininger YM. Tumor necrosis factor-alpha inhibits myogenesis through redox-dependent and -independent pathways. Am J Physiol Cell Physiol 2002; 283: C714-21.
87. Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS Jr. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 2000; 289: 2363-6.
88. Langen RC, Schols AM, Kelders MC, Wouters EF, Janssen- Heininger YM. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. Faseb J 2001; 15: 1169-80.
89. Sabourin LA, Rudnicki MA. The molecular regulation of myogenesis. Clin Genet 2000; 57: 16-25.
90. Dirks AJ, Leeuwenburgh C. The role of apoptosis in age-related skeletal muscle atrophy. Sports Med 2005; 35: 473-83.
91. McArdle A, Maglara A, Appleton P, Watson AJ, Grierson I, Jackson MJ. Apoptosis in multinucleated skeletal muscle myotubes. Lab Invest 1999; 79: 1069-76.
92. Alway SE, Siu PM. Nuclear apoptosis contributes to sarcopenia. Exerc Sport Sci Rev 2008; 36: 51-7. PMCID: 2778230.
93. Dirks AJ, Leeuwenburgh C. Aging and lifelong calorie restriction result in adaptations of skeletal muscle apoptosis repressor, apoptosis-inducing factor, X-linked inhibitor of apoptosis, caspase- 3, and caspase-12. Free Radic Biol Med 2004; 36: 27-39.
94. Alway SE, Degens H, Krishnamurthy G, Smith CA. Potential role for Id myogenic repressors in apoptosis and attenuation of hypertrophy in muscles of aged rats. Am J Physiol Cell Physiol 2002; 283: C66-76.
95. Pistilli EE, Jackson JR, Alway SE. Death receptor-associated pro-apoptotic signaling in aged skeletal muscle. Apoptosis 2006; 11: 2115-26.
96. Phillips T, Leeuwenburgh C. Muscle fiber specific apoptosis and TNF-alpha signaling in sarcopenia are attenuated by life-long calorie restriction. Faseb J 2005; 19: 668-70.
97. Chabi B, Ljubicic V, Menzies KJ, Huang JH, Saleem A, Hood DA. Mitochondrial function and apoptotic susceptibility in aging skeletal muscle. Aging Cell 2008; 7: 2-12.
98. Cadenas E. Mitochondrial free radical production and cell signaling. Mol Aspects Med 2004; 25: 17-26.
99. Nitahara JA, Cheng W, Liu Y et al. Intracellular calcium, DNase activity and myocyte apoptosis in aging Fischer 344 rats. J Mol Cell Cardiol 1998; 30: 519-35.
100. Squier TC, Bigelow DJ. Protein oxidation and age-dependent alterations in calcium homeostasis. Front Biosci 2000; 5: D504-26.
101. Siu PM, Pistilli EE, Butler DC, Alway SE. Aging influences cellular and molecular responses of apoptosis to skeletal muscle unloading. Am J Physiol Cell Physiol 2005; 288: C338-49.
102. Marzetti E, Wohlgemuth SE, Lees HA, Chung HY, Giovannini S, Leeuwenburgh C. Age-related activation of mitochondrial caspaseindependent apoptotic signaling in rat gastrocnemius muscle. Mech Ageing Dev 2008; 129: 542-9. PMCID: 2585824.
103. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR, Cohen GM. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 1999; 274: 5053-60.
104. Baumgartner RN. Body composition in healthy aging. Ann NY Acad Sci 2000; 904: 437-48.
105. Roubenoff R. Sarcopenic obesity: the confluence of two epidemics. Obes Res 2004; 12: 887-8.
106. Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis 2008; 18: 388-95.
107. Song MY, Ruts E, Kim J, Janumala I, Heymsfield S, Gallagher D. Sarcopenia and increased adipose tissue infiltration of muscle in elderly African American women. Am J Clin Nutr 2004; 79: 874-80.
108. Cree MG, Newcomer BR, Katsanos CS et al. Intramuscular and liver triglycerides are increased in the elderly. J Clin Endocrinol Metab 2004; 89: 3864-71.
109. Cesari M, Kritchevsky SB, Baumgartner RN et al. Sarcopenia, obesity, and inflammation - results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am J Clin Nutr 2005; 82: 428-34.
110. Jensen GL. Inflammation: roles in aging and sarcopenia. JPEN J Parenter Enteral Nutr 2008; 32: 656-9.
111. Yende S, Waterer GW, Tolley EA et al. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax 2006; 61: 10-6.
112. Mundy GR. Osteoporosis and inflammation. Nutr Rev 2007; 65: 147-51.
113. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (New York) 1993; 259: 87-91.
114. Marzetti E, Leeuwenburgh C. Skeletal muscle apoptosis, sarcopenia and frailty at old age. Exp Gerontol 2006; 41: 1234-8.
115. Roubenoff R. Sarcopenic obesity: the confluence of two epidemics. Obes Res 2004; 12: 887-8.
116. Peterson MD, Liu D, Gordish-Dressman H et al. Adiposity attenuates muscle quality and the adaptive response to resistance exercise in non-obese, healthy adults. Int J Obes (Lond) 2011; 35: 1095-103. doi: 10.1038/ijo.2010.257. Epub 2010 Dec 7.
117. Awad AB, Bradford PG. Adipose tissue and inflammation. Boca Raton, FL: Taylor & Francis, 2010.
118. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007; 56: 1010-3.
119. Neels JG, Olefsky JM. Inflamed fat: what starts the fire? J Clin Invest 2006; 116: 33-5. PMCID: 1323268.
120. Zamboni M, Mazzali G, Zoico E et al. Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes (Lond) 2005; 29: 1011-29.
121. Coll T, Barroso E, Alvarez-Guardia D et al. The role of peroxisome proliferator-activated receptor beta/delta on the inflammatory basis of metabolic disease. PPAR Res 2010; 2010. PMCID: 2913795.
122. Coll T, Alvarez-Guardia D, Barroso E et al. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells. Endocrinology 2010; 151: 1560-9.
123. Perseghin G, Petersen K, Shulman GI. Cellular mechanism of insulin resistance: potential links with inflammation. Int J Obes Relat Metab Disord 2003; 27 (Suppl 3): S6-11.
124. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996; 27: 665-8.